Neonatal pharmacology and clinical implications
During the neonatal period, there is physiological immaturity of organs, systems and metabolic pathways that influences the pharmacokinetics and pharmacodynamics of administered drugs, the dosage of which should be constantly amended, considering the progressive increase in weight and the maturation...
Saved in:
Main Authors: | Antonio Ruggiero (Author), Anna Ariano (Author), Silvia Triarico (Author), Michele Antonio Capozza (Author), Pietro Ferrara (Author), Giorgio Attinà (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Temozolomide and oral etoposide in children with recurrent malignant brain tumors
by: Antonio Ruggiero, et al.
Published: (2020) -
Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
by: Antonio Ruggiero, et al.
Published: (2020) -
Transdermal buprenorphine for pain management in children
by: Giorgio Attinà, et al.
Published: (2021) -
Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study
by: Michele Antonio Capozza, et al.
Published: (2024) -
Facing the COVID-19 outbreak in children with cancer
by: Antonio Ruggiero, et al.
Published: (2020)